Previous Close | 22.84 |
Open | 23.50 |
Bid | 24.20 x 100 |
Ask | 24.37 x 100 |
Day's Range | 22.77 - 25.91 |
52 Week Range | 9.26 - 26.70 |
Volume | |
Avg. Volume | 234,025 |
Market Cap | 671.683M |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
FRIENDSWOOD, Texas, May 03, 2024--Castle Biosciences will share new data supporting the utility of its DecisionDx®-SCC test at the ACMS Annual Meeting in Phoenix.
FRIENDSWOOD, Texas, May 02, 2024--Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced its financial results for the first quarter ended March 31, 2024.
FRIENDSWOOD, Texas, April 30, 2024--Castle Biosciences announced its support of key skin cancer advocacy events and initiatives throughout May in honor of Skin Cancer Awareness Month.